There Is A Quest For Clarity Surrounding Boston Scientific Corp. (NYSE: BSX) Volatility

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Boston Scientific Announces Results for Fourth Quarter and Full Year 2023.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

This NYSE-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $64.82 and fluctuated between $64.90 as its day high and $63.39 as its day low. The current market capitalization of Boston Scientific Corp. is $94.96B. A total of 10.53 million shares were traded on the day, compared to an average of 6.59M shares.

Insider Activity

Insider trades can also provide insight into a stock’s future direction. During the recent three months, BSX has seen 4 BUY and 3 SELL insider trades, representing the acquisition of 119,764 and the disposition of 129,027 shares. Over the last 12 months, there were 101 BUYs and 97 SELLs from insiders. Insiders purchased 930,687 shares during that period but sold 1,284,584.

In the most recent transaction, Fitzgerald Joseph Michael sold 11,660 shares of BSX for 60.00 per share on Jan 12. After the transaction, the EVP & Group Pres, Cardiology now owns 173,472 company shares. In a previous transaction on Jan 09, Mirviss Jeffrey B. sold 15,172 shares at 59.25 per share. BSX shares that EVP&Pres, Periph Intervent owns now total 56,588.

Among the insiders who sold shares, Mirviss Jeffrey B. disposed of 15,000 shares on Jan 04 at a per-share price of $58.40. This resulted in the EVP&Pres, Periph Intervent holding 56,588 shares of BSX after the transaction. In another insider transaction, Mirviss Jeffrey B. sold 11,931 shares at $57.82 per share on Jan 03. Company shares held by the EVP&Pres, Periph Intervent now total 56,588.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for BSX in the last 3 months, the mean price target is $70.56 with high estimates of $81.00 and low estimates of $61.00. In terms of 52-week highs and lows, BSX has a high of $64.49 and a low of $45.92.

As of this writing, BSX has an earnings estimate of $Blackstone Inc. per share for the current quarter. EPS was calculated based on a consensus of Phillips 66 estimates, with a high estimate of $Becton, Dickinson and Company per share and a lower estimate of $Boston Scientific Corporation.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. BSX’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $9.45B in debt and $4.27B in liabilities at the time. Its Book Value Per Share was $12.89, while its Total Shareholder’s Equity was $16.62B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BSX is Buy with a score of 4.61.

Most Popular

Related Posts